Evidence map›Paper›PMID 11503960›Full record

ArticleInternational journal of hematology2001

Defective megakaryopoiesis and abnormal erythroid development in Fli-1 gene-targeted mice.

Hiroshi Kawada, Tatsuya Ito, Pamela N Pharr, Demetri D Spyropoulos, Dennis K Watson, Makio Ogawa

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of hematology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 76 citations in OpenAlex.

  1. Identification of dynamic driver sets controlling phenotypical landscapes.Computational and structural biotechnology journal · 2022
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. [The role of PDK1 in the transition of endothelial to hematopoietic cells].Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi · 2018
    Article
  9. Article
  10. Article
  11. Haematologica · 2017
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hiroshi KawadaDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Tatsuya ItoDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Pamela N PharrDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Demetri D SpyropoulosDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Dennis K WatsonDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA.
Makio OgawaDepartment of Medicine, Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA. ogawam@musc.edu.
MUSC Hollings Cancer Center · USMedical University of South Carolina · US

Funding

THE ROLE OF FLI1 IN CELLULAR DIFFERENTIATION AND DEVELOPMENTP01CA078582 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI TROJANOWSKA, MARIA · 1998 to 2009
$9.1M
IDENTIFICATION AND PURIFICATION OF HUMAN STEM CELLSR01DK054197 · NIDDK · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI OGAWA, MAKIO · 1998 to 2001
$625k
NCI NIH HHS P01-CA78582NIDDK NIH HHS R01-DK54197
6 · The paper itself

Abstract

Mouse embryos homozygous for a targeted disruption in the Fli-1 gene show hemorrhage into the neural tube and brain on embryonic day (E)11.0 and die shortly thereafter. Livers from the mutant embryos contain drastically reduced numbers of pronormoblasts, basophilic normoblasts, and colony-forming cells. To determine the nature of impaired hematopoiesis, we carried out cell culture studies of mutant embryonic stem (ES) cells and cells from the aorta-gonad-mesonephros (AGM) region of E10.0 mutant embryos. There was a striking reduction in the number of megakaryocytes in cultures of mutant AGM cells compared with cultures of AGM cells from wild-type or heterozygous embryos. Furthermore, Fli-1 mutant ES cells failed to produce megakaryocyte colonies and multilineage colonies containing megakaryocytes. Consistent with the observed defect in megakaryopoiesis, we also demonstrated the down-regulation of c-mpl in the AGM of mutant embryos. The percentages of pronormoblasts and basophilic normoblasts were significantly reduced in cultures of mutant AGM embryos, which contained primarily polychromatophilic and orthochromatic normoblasts. These results provide further evidence for the role of Fli-1 in the regulation of hematopoiesis and for c-mpl as a Fli-1 target gene.

Indexed as

Proto-Oncogene ProteinsAnimalsCells, CulturedDNA-Binding ProteinsDown-RegulationEmbryo, MammalianErythroid Precursor CellsErythropoiesisHematopoiesisMegakaryocytesMiceMice, Mutant StrainsProto-Oncogene Protein c-fli-1ThrombopoietinTrans-ActivatorsDNA-Binding ProteinsFli1 protein, mouseProto-Oncogene Protein c-fli-1Proto-Oncogene ProteinsThrombopoietinTrans-Activators

Identifiers

PMID11503960
OpenAlexW2084775802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.